MCG Wada Protocol: Clinical Core General Baseline language and memory performance is obtained on a separate day by going through the entire protocol in the patient's hospital room. The Wada test itself is conducted by a neuropsychologist with the assistance of a neurologist. The testing is performed immediately following cerebral angiography, and both hemispheres are studied on the same day. Patients begin counting repeatedly from 1-20 with their hands held up and their palms turned rostrally and fingers spread. An injection of 100 mg amobarbital sodium is administered by hand over a 4-5 second interval via a percutaneous transfemoral catheter. Following demonstration of hemiplegia and evaluation of eyegaze deviation, the patient is requested to execute a simple midline command (e.g., "touch your nose"). Beginning approximately 30-45 seconds following injection, eight common objects are presented for 4-8 seconds each, and the object names are repeated twice to the patient. Examples of Wada memory items include a combination of ordinary household items (e.g., fork, mousetrap), small toys (e.g., troll), and plastic food (e.g., hotdog, pizza). At times, due to patient confusion, inattention, or non-responsiveness, the patient's eyes are held open. Language is assessed in detail following presentation of memory items. Recognition memory of material presented during the procedure is tested after amobarbital effects have worn off as demonstrated by return baseline language performance on all tasks described below, return of 5/5 strength, and absence of pronator drift, tactile extinction, asterixis and bradykinesia. Language Language rating is based upon performance on five linguistic tasks (viz., counting disruption, comprehension, naming, repetition, and reading). Although we have developed a formalized approach to calculate a language laterality ratio, this is for research purposes and is not routinely used clinically. Expressive Language/Counting. The expressive language score (0-4) is based upon disruption of counting ability at the initiation of the Wada test (4 = normal, slowed, or brief pause < ~20 seconds; 3 = counting perseveration with normal sequencing; 2 = sequencing errors; 1 = single number or word perseveration; 0 = arrest > ~20 seconds). We have adopted a period of speech arrest of this duration to insure that counting interruption is not due to acute generalized disruptive effects of the medication. If speech arrest occurs, patients are repeatedly urged to begin counting again starting with "1" since the more overlearned portion of the sequence will be less likely disrupted from generalized medication effects. Comprehension. Simple comprehension is assessed after assessment of eyegaze deviation by requesting the patient to execute a simple midline command (e.g., "stick out your tongue"). Following object memory stimulus presentation, comprehension is more systematically assessed with a modified token test. The token test consists of four geometric shapes of different colors which are presented vertically to the subject's ipsilateral visual field. Comprehension is rated based upon the level of syntactic complexity in the command that is correctly executed: 1. "point to the blue circle after the red square," 2. "point to the red circle and then point to the blue square," 3. "point to the red square." A score of 3 is awarded for completion of a complex two-stage command with inverted syntax, a score of 2 reflects successful simple two-stage command, 1 is scored for one-stage commands, and 0 if the subject cannot perform any commands. Confrontation Naming. Two line drawings of common objects (i.e., watch and jacket) are presented and the subject is asked to name the objects and parts of the objects (e.g., watchband, collar). Performance is qualitatively scored on a 0-3 point scale. Repetition. Following object naming, the patient repeats phases (e.g., "No ifs, ands, or buts") and repetition is graded on a 0-3 rating scale. If unable to provide any response, the patient is asked to repeat "Mary had a little lamb." Reading. Patients are asked to read either "The car backed over the curb" or "The rabbit hopped down the lane." Performance is rated on a 0-3 point scale. General Language Considerations. When language impairments are present, language stimuli are presented throughout the recovery phase to monitor drug effects. The time of complete language recovery is noted. The same or alternative stimuli as those employed during the initial assessment are used with the exception of repetition. Repetition is a very sensitive measure of mild language impairment, and additional repetition items such as "Methodist-Episcopal" and sentences from the Boston Diagnostic Aphasia Examination are used to monitor recovery (e.g., The spy fled to Greece). Positive paraphasic responses are considered the single strongest evidence of language representation in the hemisphere being studied. Memory A minimum of 10 minutes following amobarbital injection is required prior to memory testing. Although free recall of object memory stimuli is obtained, interpretation of Wada memory performance is based solely on object recognition. Ipsilateral Performance. Each of the 8 objects are presented randomly interspersed with 16 foils, and forced choice recognition is obtained. One-half the number of false positive responses is subtracted from the number of objects correctly recognized to correct for possible response bias and guessing. Thus, the expected score in the absence of true recognition is 0. Laterality Scores. Since Wada memory scores are used to assist in seizure onset lateralization by demonstrating lateralized dysfunction, the order of injection is randomized across subjects and memory results are interpreted in a blind fashion. To assess lateralized asymmetries, interhemispheric Wada memory difference scores (i.e., [left injection] - [right injection]) derived from corrected memory performances are computed; positive scores suggest left temporal lobe dysfunction and negative scores suggest right temporal lobe impairment. General Memory Considerations. Fixed pass/fail criteria are not employed for memory performance following injection ipsilateral to the seizure onset. However, we generally require a score of at least 2/8 in order to not repeat the Wada memory assessment, and are more comfortable with scores of at least 3/8 correct. Asymmetries of at least 2 are interpreted as evidence of lateralized impairment, although greater asymmetries are interpreted with more confidence. As with the ipsilateral performance, the asymmetries scores are not considered absolute, and memory performance is always considered in the context of other clinical factors such as consistency of seizure onset or presence of a structural lesion such as tumor or hippocampal atrophy on MRI. Although asymmetries in the "wrong" direction are sometimes observed, when they are present, they are cause for particular concern and the procedure may be repeated bilaterally using a 75 mg dose and beginning on the side ipsilateral to the presumed seizure onset. (c) 1995, Medical College of Georgia